SK4012000A3 - Method for purification of antithrombin iii - Google Patents

Method for purification of antithrombin iii Download PDF

Info

Publication number
SK4012000A3
SK4012000A3 SK401-2000A SK4012000A SK4012000A3 SK 4012000 A3 SK4012000 A3 SK 4012000A3 SK 4012000 A SK4012000 A SK 4012000A SK 4012000 A3 SK4012000 A3 SK 4012000A3
Authority
SK
Slovakia
Prior art keywords
iii
complex
heparin
heparinoid
atiii
Prior art date
Application number
SK401-2000A
Other languages
English (en)
Slovak (sk)
Inventor
Yendra Linnau
Ernst Hetzl
H Peter Matthiessen
Silvia Neppl
Wolfgang Schonhofer
Hans-Peter Schwarz
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Ag filed Critical Baxter Ag
Publication of SK4012000A3 publication Critical patent/SK4012000A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8128—Antithrombin III
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK401-2000A 1997-09-19 1998-09-17 Method for purification of antithrombin iii SK4012000A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0159497A AT405739B (de) 1997-09-19 1997-09-19 Verfahren zur reinigung von antithrombin iii
PCT/AT1998/000223 WO1999015562A1 (de) 1997-09-19 1998-09-17 Verfahren zur reinigung von antithrombin iii

Publications (1)

Publication Number Publication Date
SK4012000A3 true SK4012000A3 (en) 2000-10-09

Family

ID=3516803

Family Applications (1)

Application Number Title Priority Date Filing Date
SK401-2000A SK4012000A3 (en) 1997-09-19 1998-09-17 Method for purification of antithrombin iii

Country Status (11)

Country Link
US (1) US6395880B1 (de)
EP (1) EP1015491A1 (de)
JP (1) JP2001517679A (de)
AT (1) AT405739B (de)
AU (1) AU742861B2 (de)
BR (1) BR9812229A (de)
CA (1) CA2303924A1 (de)
HU (1) HUP0003671A1 (de)
NO (1) NO20001414L (de)
SK (1) SK4012000A3 (de)
WO (1) WO1999015562A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070123251A1 (en) * 1996-10-23 2007-05-31 Riparius Ventures, Llc Remote internet telephony device
EP3708581A3 (de) 2009-05-27 2021-10-20 Takeda Pharmaceutical Company Limited Verfahren zur herstellung eines hochkonzentrierten immunglobulinpräparats zur subkutanen verwendung
CA2774053C (en) 2009-09-17 2015-04-28 Baxter Healthcare, S.A. Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof
DE102016009442A1 (de) * 2016-08-03 2018-02-08 Fresenius Medical Care Deutschland Gmbh Verfahren zur Überwachung des Bicarbonat-Gehalts und des Natrium-Gehalts einer Dialyselösung
EP3560946B1 (de) 2016-12-22 2022-02-02 KM Biologics Co., Ltd. Chromatografisches verfahren zur entnahme des blutgerinnungsfaktors vii mit hoher ausbeute
BR102017005783A2 (pt) * 2017-03-21 2018-10-02 Fund Butantan processo de obtenção de esculptina e seus fragmentos, esculptina recombinante e seus usos

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE392038B (sv) 1971-09-08 1977-03-14 Kabi Ab Forfarande for isolering av antitrombin ur blod eller blodprodukter
US4286056A (en) * 1980-01-28 1981-08-25 Baxter Travenol Laboratories, Inc. Method for making therapeutic enzyme compositions
AT379310B (de) * 1983-05-20 1985-12-27 Immuno Ag Verfahren zur herstellung eines antithrombin iii-heparin- bzw. antithrombin iii-heparinoidkonzentrates
US4540573A (en) 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
AT389815B (de) 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
US4749783A (en) 1986-07-11 1988-06-07 Miles Laboratories, Inc. Viral inactivation and purification of active proteins
AT402891B (de) 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
US5319072A (en) * 1992-01-10 1994-06-07 Alpha Therapeutic Corporation Human antithrombin-III preparation
JP3133338B2 (ja) 1992-12-16 2001-02-05 イムノ・アクチエンゲゼルシャフト ウイルス的に安全な生物学的組成物の調製方法
DE4434538C2 (de) 1993-10-06 2000-08-10 Immuno Ag Verfahren zur Virusinaktivierung in Gegenwart eines Polyethers und eines chaotropen Agens

Also Published As

Publication number Publication date
WO1999015562A1 (de) 1999-04-01
US6395880B1 (en) 2002-05-28
HUP0003671A1 (hu) 2001-02-28
AT405739B (de) 1999-11-25
NO20001414L (no) 2000-05-18
BR9812229A (pt) 2000-07-18
EP1015491A1 (de) 2000-07-05
CA2303924A1 (en) 1999-04-01
ATA159497A (de) 1999-03-15
JP2001517679A (ja) 2001-10-09
AU742861B2 (en) 2002-01-17
NO20001414D0 (no) 2000-03-17
AU9244898A (en) 1999-04-12

Similar Documents

Publication Publication Date Title
US5886154A (en) Chromatographic method for high yield purification and viral inactivation of antibodies
US6955917B2 (en) Chromatographic method for high yield purification and viral inactivation of antibodies
CZ328795A3 (en) Concentrate of immunoglobulins g for therapeutical use and process for preparing thereof
EP2321336A1 (de) Verfahren zur herstellung eines alpha-1-proteinaseinhibitors
CA2059979C (en) Complex containing coagulation factor ix
CA2491716A1 (en) Processes for the preparation of fibrinogen
SK4012000A3 (en) Method for purification of antithrombin iii
HU219828B (hu) Eljárás K-vitamin-függő proteinek izolálására és tisztítására
US7041798B1 (en) Method for the chromatographic fractionation of plasma or serum, preparations, so obtained, and their use
Burnouf et al. Application of bioaffinity technology in therapeutic extracorporeal plasmapheresis and large-scale fractionation of human plasma
US5744586A (en) Manufacturing process for the production of purified transferrin
CZ2000983A3 (cs) Způsob čištění antithrombinu III
EP0815873B1 (de) Selektive Stabilisierung von Proteinen während Inaktivierung von Viren, durch Bindung an immobilizierte Affinitätsligande
MXPA00002620A (en) Method for purification of antithrombin iii
SK284215B6 (sk) Spôsob výroby frakcie s inaktivovanými vírusmi obsahujúcej faktor VIII
WO2000034453A1 (en) PURIFICATION OF α1-PROTEINASE INHIBITOR
AU729682C (en) Manufacturing process for the production of purified transferrin
KR830001822B1 (ko) 유로 키나제의 제조방법
JPH03277274A (ja) 大腸菌由来物質の除去方法